Search

everythinglearnresearchcommunity

for

Search:↓

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

The combination of minoxidil, microneedling, and PRP is more effective for hair growth than minoxidil alone.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

PDRN is effective and safe for healing wounds and skin issues.

Applying a special compound can promote hair growth without harmful side effects.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

PRX01, PRX44, and PRX73 affect root hair growth by interacting with extensins in Arabidopsis.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Glycine likely affects dendrites connected to hair follicle terminals in rats.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

PRP therapy with specific growth factors improves hair density and thickness in androgenic alopecia.

4-azasteroids, including finasteride, can inhibit 5α-reductase, helping treat conditions like enlarged prostate and hair loss.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Lower allopregnanolone levels increase stress-related dopamine release in the brain.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

New compounds were found to help increase hair growth and decrease hair loss.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Gene differences affect finasteride side effects in men with hair loss.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.